Commercialization: Page 8
-
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: CinCor Pharma’s Terry Coelho
From M&Ms to biotech, the chief financial officer’s sweet tooth for taking risks is paying off.
By Taren Grom • July 6, 2022 -
iStock via Getty Images
Pharma companies take a fresh approach to inclusion in new DTC ads
AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.
By Karissa Waddick • July 5, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Novartis’ Marie-France Tschudin
How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.
By Taren Grom • June 29, 2022 -
iStock via Getty Images
With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control’s pain points
The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.
By Karissa Waddick • June 28, 2022 -
iStock via Getty Images
A myriad of blows: Who’s getting hit the hardest by the economy’s troubles
The downturn shows few signs of hurting large pharma, but small biotechs and generics makers could face a credit crunch.
By Kim Ribbink • June 27, 2022 -
Drew Angerer / Staff via Getty Images
TikTok tutorial: How pharma can embrace the video platform’s educational potential
Ogilvy Health’s director of social strategy, Katie Ferrigno, busts myths and provides tips on how biopharmas can take advantage of TikTok’s unique features to connect with patients.
By Karissa Waddick • June 15, 2022 -
iStock via Getty Images
Aduhelm’s Medicare woes leave questions about lofty premiums
A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.
By Kelly Bilodeau • June 2, 2022 -
Permission granted by Flagship Pioneering/Avak Kahvejian.
ProfileFlagship’s creative approach to finding the next big idea in biopharma
Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.
By Alexandra Pecci • June 1, 2022 -
George Marks via Getty Images
PBMs under fire for drug prices defend their worth
A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they’re more than just middlemen.
By Michael Gibney • May 26, 2022 -
John Moore via Getty Images
A potential COVID-19 EUA could turn this small biotech into a household name
Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.
By Meagan Parrish • May 19, 2022 -
iStock via Getty Images
Q&AIronwood Pharmaceuticals is charting a course to become a giant in GI
Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market.
By Karissa Waddick • May 19, 2022 -
iStock via Getty Images
It’s time to acknowledge access as a prescribing barrier
A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs.
By Karissa Waddick • May 11, 2022 -
Stock via Getty Images
Q&A // Biotech SpotlightBiotech Spotlight: Everest Medicines takes aim at unmet needs in Asia
With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.
By Taren Grom • May 9, 2022 -
Adobe Stock / Song about summer
Sponsored by EVERSANARight-sizing the channel strategy for maximum impact
Failure to right-size your distribution model imposes financial penalties and wasted expenditures.
May 9, 2022 -
iStock via Getty Images
Pharma’s solution to the digital advertising dilemma? Storytelling
Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.
By Karissa Waddick • May 5, 2022 -
Stock via Getty Images
From the fringes to the forefront — the mRNA era has taken hold of pharma
A look at what’s next for the industry’s buzziest technology.
By Kim Ribbink • April 22, 2022 -
Permission granted by Ted Love.
ProfileFor Global Blood Therapeutics, the connection to sickle cell disease runs deep
An underserved patient population is a guiding light for the company, which recently scored a new approval.
By Robin Robinson • April 19, 2022 -
Justin Sullivan / Staff via Getty Images
Q&AHow pharma can up its social media game
Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities.
By Karissa Waddick • April 18, 2022 -
Win McNamee/Staff via Getty Images
How Congress could play a role in personalized medicine
PGx — a tool to help determine proper dosing — may be poised to achieve broader use in healthcare and pharma.
By Kelly Bilodeau • April 11, 2022 -
Ilya Lukichev via Getty Images
Optinose CEO senses big opportunities for the company’s nasal delivery device
Peter Miller explains how a repackaged sinus drug has won late-stage clinical success.
By Jared Whitlock • April 11, 2022 -
Stock via Getty Images
Q&ATime-saving tech lights Alcon’s path into digital innovation
Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a North Star when developing digital tools.
By Kim Ribbink • April 4, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Daré Bioscience’s Sabrina Martucci Johnson
The CEO is setting a path to transform women’s health at an opportune time.
By Taren Grom • March 30, 2022 -
Permission granted by Alloy.
ProfileFrom media to menopause: Creating new spaces in women’s telehealth
Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women’s health startup.
By Alexandra Pecci • March 29, 2022 -
Permission granted by Steve Leber.
How a rock ‘n’ roll guru is putting a new spin on health education for patients
A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.
By Meagan Parrish • March 28, 2022 -
Stock via Getty Images
Q&AWhy Astellas is adopting a ‘focus area approach’ to partnerships
Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.
By Kim Ribbink • March 22, 2022
Previous
